(Press-News.org) BOSTON - New research in humans and mice identifies a particular signaling molecule that can help modify inflammation and the immune system to protect against Alzheimer's disease. The work, which was led by investigators at Massachusetts General Hospital (MGH), is published in Nature.
Cognitive decline associated with Alzheimer's disease develops when neurons begin to die. "Neuron death can be caused by improper immune responses and excessive neuroinflammation--or inflammation in the brain--triggered by high levels of amyloid beta deposits and tau tangles, two hallmarks of Alzheimer's disease," explains the paper's co-senior author Filip Swirski, PhD, who conducted the work while a principal investigator in the Center for Systems Biology at MGH.
"Once neurons start dying in increasing amounts, brain cells called microglia and astrocytes--which are normally nurturing cells that clean up debris--become activated to cause neuroinflammation in an attempt to protect the brain. They are evolutionarily programmed to wipe out a brain region where there is excess neuronal cell death because it may be due to an infection, which must be stopped from spreading," explains co-senior author Rudolph Tanzi, PhD, co-director of the McCance Center for Brain Health at MGH.
In the case of Alzheimer's disease, the neuronal cell death brought on by amyloid beta deposits and tau tangles activates this response. "As neuroinflammation ensues, the amount of cell death is at least 10 times higher than that which was caused by plaques and tangles," says Tanzi. "In fact, without the induction of neuroinflammation, there would be no symptoms of dementia. We know this from 'resilient' brains, in which there are lots of plaques and tangles in an individual's brain but no symptoms at death because there was minimal or no neuroinflammation." Tanzi provides an analogy, noting that amyloid beta is the "match" that lights the spreading "brushfires" of tangles, but only when this leads to increasing numbers of "forest fires" through neuroinflammation that is activated by microglia and astrocytes does one lose enough neurons to suffer cognitive decline and dementia.
This new study in Nature revealed that a subset of astrocytes actually tries to put out the fire by releasing a molecule called interleukin-3 (IL-3), which then converts killer microglial cells back into nurturing and protective cells that no longer wipe out neurons and instead focus on cleaning out amyloid beta deposits and tau tangles.
"There may be important clinical implications to knowing that astrocytes talk to microglia via IL-3 to educate the microglia and help them decrease the severity of Alzheimer's disease," says Swirski. "We can now think about how to use IL-3 to not only help curb the neuroinflammation that carries out the bulk of neuronal cell death in Alzheimer's disease, but also to entice microglia to once again take on the beneficial task of clearing away the deposits and tangles that are the initiating pathology of Alzheimer's disease."
"It was surprising to find IL-3 in the brain," says first author Cameron McAlpine, PhD, then an instructor in the Center for Systems Biology. "Our findings suggest that communication between astrocytes and microglia, via IL-3, is an important mechanism that wards off Alzheimer's disease by instructing microglia to adapt protective functions. With further study, IL-3 signaling may provide a new therapeutic opportunity to combat neurological diseases."
INFORMATION:
Tanzi is vice chair of Neurology and director of the Genetics and Aging Research Unit at MGH. Swirski is director of the Cardiovascular Research Institute and professor of Medicine (Cardiology) and Diagnostic Molecular and Interventional Radiology at the Icahn School of Medicine at Mount Sinai in New York City. McAlpine is assistant professor of Medicine (Cardiology) and Neuroscience at the Icahn School of Medicine. Study co-authors include Joseph Park, Ana Griciuc, Eunhee Kim, Se Hoon Choi, PhD, Yoshiko Iwamoto, Máté G. Kiss, Kathleen A. Christie, Claudio Vinegoni, PhD, Wolfram C. Poller, John E. Mindur, Christopher T. Chan, Shun He, Henrike Janssen, Lai Ping Wong, Jeffrey Downey, Sumnima Singh, Atsushi Anzai, PhD, Florian Kahles, MD, Mehdi Jorfi, Paolo Fumene Feruglio, Ruslan I. Sadreyev, Ralph Weissleder, MD, PhD, Benjamin P. Kleinstiver, and Matthias Nahrendorf, MD, PhD.
The study was funded by the Cure Alzheimer's Fund, the National Institutes of Health, the Patricia and Scott Eston MGH Research Scholar, a Canadian Institutes of Health Research Banting Fellowship, and a Kirschstein National Research Service Award Individual Predoctoral Fellowship.
About the Massachusetts General Hospital
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2020, Mass General was named #6 in the U.S. News & World Report list of "America's Best Hospitals."
BOSTON - Over the last decade, investigators at Beth Israel Deaconess Medical Center (BIDMC) have been at the forefront of the effort to END ...
New York, NY--July 14, 2021-- A previously unknown kind of human brain cell appears to help people center themselves in their personal maps of the world, according to a new study from neuroscientists at Columbia Engineering. This discovery sheds light on the cellular mechanisms underlying navigation and memory in humans, as well as what parts of the brain might get disrupted during the kinds of memory impairments common in neurodegenerative diseases such as Alzheimer's.
There are two strategies with which humans and animals navigate and orient themselves. One involves locating places, distances and directions in "allocentric" or other-centered ...
What The Study Did: The COVID-19 pandemic was associated with a decline in addiction treatment initiations but more research is needed to understand the cause of the decline in initiations and the extent to which it was due to reduced demand for services or reduced ability to supply treatment.
Authors: Tami L. Mark, Ph.D., M.B.A., of RTI International in Rockville, Maryland, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.17029)
Editor's Note: The article ...
What The Study Did: In this randomized clinical trial, a physician messaging campaign was effective in increasing COVID-19 knowledge, information-seeking and self-reported protective behaviors among diverse groups.
Authors: Esther Duflo, Ph.D., of the Massachusetts Institute of Technology in Cambridge, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.17115)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # ...
What The Study Did: About half the women experiencing homelessness and unstable housing who were surveyed experienced symptoms of depression or anxiety or both during the pandemic and, in addition to unmet subsistence needs and social isolation, these symptoms were associated with increased challenges accessing non-COVID-19 care and managing symptoms for chronic medical conditions.
Authors: Elise D. Riley, Ph.D., M.P.H., of the University of California, San Francisco, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.17035)
Editor's ...
What The Study Did: This study found an unequal pattern of COVID-19 outcomes that was associated with the socioeconomic circumstances in regions of Japan, suggesting that these disparities in COVID-19 outcomes aren't unique to the United States and Europe.
Authors: Yuki Yoshikawa, M.D., M.P.H., of the Harvard T.H.Chan School of Public Health in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.17060)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# ...
The COVID-19 pandemic has amplified calls to end the detention of migrant children, as cases surge among children held in crowded conditions; yet immigration detention's threats to children's fundamental rights did not begin with the current public health crisis.
Unlike nearly three-quarters of high-income countries, however, the U.S. has no laws specifically limiting the detention of accompanied migrant and asylum-seeking children, according to a new study by the UCLA Fielding School of Public Health's END ...
A football is not a quantum particle. There are crucial differences between the things we know from everyday life and tiny quantum objects. Quantum phenomena are usually very fragile. To study them, one normally uses only a small number of particles, well shielded from the environment, at the lowest possible temperatures.
Through a collaboration between the University of Vienna, the Austrian Academy of Sciences and TU Wien, however, it has now been possible to measure a hot glass sphere consisting of about one billion atoms with unprecedented precision and to control it at the quantum level. Its movement was deliberately slowed down until it assumed the ground state of lowest possible ...
Mitotic Catastrophe Database (MCDB) is a proprietary, standard, and comprehensive database for Mitotic catastrophe (MC) related data facilitating the exploration of MC for all researchers in the fields of medicinal chemistry, molecular biology, bioinformatics and oncology.
MC is a form of programmed cell death induced by mitotic process disorders, which is important in tumor prevention, development, and drug resistance. As availability of MC data underpins tumor-related biomedical and clinical studies, the development of a professional and comprehensive database to curate MC-related data is a matter of increasing priority.
MCDB consists of 1214 genes/proteins and 5014 compounds ...
Jacksonville, Fla. - A recent qualitative research study conducted by the University of North Florida, in partnership with Indianan University-Purdue Indianapolis and UF Health Jacksonville, shows that black teenage girls want inclusive body types to be featured in advertising to combat teen obesity rates. Insights provided in the study are ideal for pediatricians and healthcare educators developing advertising and patient care plans to combat obesity among African American teens.
The study investigated social and cultural consequences of food consumption among African American teenage girls between the ages of 14-18 in Jacksonville, Fla., and explored best practices ...
